CG Oncology (CGON) Operating Expenses (2023 - 2026)

CG Oncology's Operating Expenses history runs 4 years deep, the most recent figure standing at $67.5 million for Q1 2026.

• Quarterly Operating Expenses rose 59.67% year-over-year to $67.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $220.0 million (up 62.91% YoY) and the FY2025 annual result came in at $194.8 million, up 68.23% from the prior year.
• Operating Expenses was $67.5 million for Q1 2026 at CG Oncology, up from $51.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $67.5 million in Q1 2026 and bottomed at $9.9 million in Q1 2023.
• A 4-year average of $33.4 million and a median of $28.3 million in 2024 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses surged 131.95% — and 2025, when it soared 32.51%.
• CG Oncology's Operating Expenses stood at $19.4 million in 2023, then soared by 98.93% to $38.5 million in 2024, then jumped by 32.51% to $51.0 million in 2025, then soared by 32.24% to $67.5 million in 2026.
• Business Quant data shows CGON's Operating Expenses at $67.5 million in Q1 2026, $51.0 million in Q4 2025, and $52.8 million in Q3 2025.